Literature DB >> 31955227

Comment on "Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis".

Erkan Cure1, Medine Cumhur Cure2.   

Abstract

Entities:  

Year:  2020        PMID： 31955227     DOI： 10.1007/s00296-020-04513-8

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


× No keyword cloud information.
  10 in total

1.  Atherogenic index of plasma may be strong predictor of subclinical atherosclerosis in patients with Behçet disease.

Authors:  E Cure; A Icli; A Ugur Uslu; R Aydoğan Baykara; D Sakiz; M Ozucan; F Yavuz; S Arslan; M Cumhur Cure; A Kucuk
Journal:  Z Rheumatol       Date:  2017-04       Impact factor: 1.372

2.  Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis.

Authors:  Aysegul Kucukali Turkyilmaz; Gul Devrimsel; Aynur Kirbas; Yuksel Cicek; Murat Karkucak; Erhan Capkin; Ferhat Gokmen
Journal:  Rheumatol Int       Date:  2013-06-25       Impact factor: 2.631

3.  Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.

Authors:  Edit Végh; György Kerekes; Anita Pusztai; Attila Hamar; Szilvia Szamosi; Andrea Váncsa; Levente Bodoki; Lilla Pogácsás; Fruzsina Balázs; Katalin Hodosi; Andrea Domján; Sándor Szántó; Zoltán Nagy; Zoltán Szekanecz; Gabriella Szűcs
Journal:  Rheumatol Int       Date:  2019-12-17       Impact factor: 2.631

4.  Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the Malmö Diet and Cancer Study.

Authors:  M Rosvall; M Persson; G Östling; P M Nilsson; O Melander; B Hedblad; G Engström
Journal:  Atherosclerosis       Date:  2015-01-31       Impact factor: 5.162

5.  Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.

Authors:  Erkan Cure; Abdullah Icli; Ali Ugur Uslu; Davut Sakiz; Medine Cumhur Cure; Rabia Aydogan Baykara; Fatma Yavuz; Sevket Arslan; Adem Kucuk
Journal:  Clin Rheumatol       Date:  2018-02-12       Impact factor: 2.980

6.  Risk factors for progression of carotid intima-media thickness and total plaque area: a 13-year follow-up study: the Tromsø Study.

Authors:  Marit Herder; Stein Harald Johnsen; Kjell Arne Arntzen; Ellisiv B Mathiesen
Journal:  Stroke       Date:  2012-05-01       Impact factor: 7.914

Review 7.  Carotid intima-media thickness progression and risk of vascular events in people with diabetes: results from the PROG-IMT collaboration.

Authors:  Matthias W Lorenz; Jackie F Price; Christine Robertson; Michiel L Bots; Joseph F Polak; Holger Poppert; Maryam Kavousi; Marcus Dörr; Eva Stensland; Pierre Ducimetiere; Kimmo Ronkainen; Stefan Kiechl; Matthias Sitzer; Tatjana Rundek; Lars Lind; Jing Liu; Göran Bergström; Liliana Grigore; Lena Bokemark; Alfonsa Friera; David Yanez; Horst Bickel; M Arfan Ikram; Henry Völzke; Stein Harald Johnsen; Jean Philippe Empana; Tomi-Pekka Tuomainen; Peter Willeit; Helmuth Steinmetz; Moise Desvarieux; Wuxiang Xie; Caroline Schmidt; Giuseppe D Norata; Carmen Suarez; Dirk Sander; Albert Hofman; Ulf Schminke; Ellisiv Mathiesen; Matthieu Plichart; Jussi Kauhanen; Johann Willeit; Ralph L Sacco; Stela McLachlan; Dong Zhao; Björn Fagerberg; Alberico L Catapano; Rafael Gabriel; Oscar H Franco; Alpaslan Bülbül; Frank Scheckenbach; Anja Pflug; Lu Gao; Simon G Thompson
Journal:  Diabetes Care       Date:  2015-07-15       Impact factor: 19.112

8.  Differences in carotid atherosclerosis between patients with ankylosing spondylitis treated with tumor necrosis factor-α antagonists and healthy matched controls.

Authors:  Enrico Maria Zardi; Maria Elena Pipita; Chiara Giorgi; Domenico Lichinchi; Domenico Maria Zardi; Antonella Afeltra
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Increased Levels of Oxidative Stress Markers, Soluble CD40 Ligand, and Carotid Intima-Media Thickness Reflect Acceleration of Atherosclerosis in Male Patients with Ankylosing Spondylitis in Active Phase and without the Classical Cardiovascular Risk Factors.

Authors:  Agata Stanek; Armand Cholewka; Tomasz Wielkoszyński; Ewa Romuk; Karolina Sieroń; Aleksander Sieroń
Journal:  Oxid Med Cell Longev       Date:  2017-08-15       Impact factor: 6.543

10.  Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.

Authors:  Małgorzata Biskup; Wojciech Biskup; Maria Majdan; Bożena Targońska-Stępniak
Journal:  Rheumatol Int       Date:  2018-05-17       Impact factor: 2.631
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.